Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice
C Wang, X Zheng, W Gai, G Wong, H Wang, H Jin… - Antiviral research, 2017 - Elsevier
Middle East respiratory syndrome coronavirus (MERS-CoV) has continued spreading since
its emergence in 2012 with a mortality rate of 35.6%, and is a potential pandemic threat …
its emergence in 2012 with a mortality rate of 35.6%, and is a potential pandemic threat …
[HTML][HTML] Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice
C Wang, X Zheng, W Gai, G Wong, H Wang… - Antiviral …, 2017 - ncbi.nlm.nih.gov
Middle East respiratory syndrome coronavirus (MERS-CoV) has continued spreading since
its emergence in 2012 with a mortality rate of 35.6%, and is a potential pandemic threat …
its emergence in 2012 with a mortality rate of 35.6%, and is a potential pandemic threat …
Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice
C Wang, X Zheng, W Gai, G Wong, H Wang, H Jin… - Antiviral Research, 2017 - infona.pl
Middle East respiratory syndrome coronavirus (MERS-CoV) has continued spreading since
its emergence in 2012 with a mortality rate of 35.6%, and is a potential pandemic threat …
its emergence in 2012 with a mortality rate of 35.6%, and is a potential pandemic threat …
Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice
C Wang, X Zheng, W Gai, G Wong… - Antiviral …, 2017 - pubmed.ncbi.nlm.nih.gov
Middle East respiratory syndrome coronavirus (MERS-CoV) has continued spreading since
its emergence in 2012 with a mortality rate of 35.6%, and is a potential pandemic threat …
its emergence in 2012 with a mortality rate of 35.6%, and is a potential pandemic threat …
Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice
C Wang, X Zheng, W Gai, G Wong, H Wang, H Jin… - Antiviral …, 2017 - hero.epa.gov
Middle East respiratory syndrome coronavirus (MERS-CoV) has continued spreading since
its emergence in 2012 with a mortality rate of 35.6%, and is a potential pandemic threat …
its emergence in 2012 with a mortality rate of 35.6%, and is a potential pandemic threat …
Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice.
C Wang, X Zheng, W Gai, G Wong, H Wang… - Antiviral …, 2016 - europepmc.org
Middle East respiratory syndrome coronavirus (MERS-CoV) has continued spreading since
its emergence in 2012 with a mortality rate of 35.6%, and is a potential pandemic threat …
its emergence in 2012 with a mortality rate of 35.6%, and is a potential pandemic threat …
Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice.
C Wang, X Zheng, W Gai, G Wong, H Wang… - Antiviral …, 2016 - europepmc.org
Middle East respiratory syndrome coronavirus (MERS-CoV) has continued spreading since
its emergence in 2012 with a mortality rate of 35.6%, and is a potential pandemic threat …
its emergence in 2012 with a mortality rate of 35.6%, and is a potential pandemic threat …